Charles Schwab Investment Management Inc Clene Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Clene Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 25,692 shares of CLNN stock, worth $9,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,692
Previous 25,692
-0.0%
Holding current value
$9,249
Previous $7,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CLNN
# of Institutions
54Shares Held
7.44MCall Options Held
48.1KPut Options Held
160K-
Vanguard Group Inc Valley Forge, PA2.62MShares$943,0930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA947KShares$340,7510.0% of portfolio
-
Lunt Capital Management, Inc. Holladay, UT513KShares$184,6300.11% of portfolio
-
Scoggin Management LP New York, NY500KShares$180,0000.08% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL474KShares$170,6860.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $22.9M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...